Refresh

Parabolic Drugs Ltd. - Research Center

533211 PARABDRUGS Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16 Mar ' 15
Income

Operating income

- 72.60 73.72 75.60 231.78
Expenses

Material consumed

- 63.49 91.95 328.52 255.84

Manufacturing expenses

- - - - 15.26

Personnel expenses

1.68 9.30 8.47 10.68 17.01

Selling expenses

- 0.03 0.04 0.04 -

Adminstrative expenses

4.73 16.24 19.15 42.75 22.26

Expenses capitalised

- - - - -

Cost of sales

6.41 89.06 119.60 381.98 310.36

Operating profit

- -16.46 -45.88 -306.39 -78.58

Other recurring income

0.02 4.11 4.25 0.31 1.24

Adjusted PBDIT

-6.39 -12.36 -41.62 -306.08 -77.34

Financial expenses

0.66 8.35 9.91 107.62 98.69

Depreciation

21.59 34.54 53.49 67.06 72.97

Other write offs

- - - - -

Adjusted PBT

-28.64 -55.24 -105.02 -480.76 -249.00

Tax charges

- 1.76 3.05 4.43 130.33

Adjusted PAT

- -57.00 -108.07 -485.19 -379.32

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

-28.64 -57.00 -108.07 -485.19 -379.32

Earnigs before appropriation

-28.64 -1,097.67 -1,040.67 -932.60 -447.75

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-28.64 -1,097.67 -1,040.67 -932.60 -447.75
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com